Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Company Overview
Mylan, Inc. is a generic and specialty pharmaceuticals company, which operates through its subsidiaries and develops, manufactures, markets and distributes pharmaceuticals.
| Name: | Mylan Inc. |
|---|---|
| Address: | 1500 Corporate Drive Canonsburg, Pennsylvania 15317 |
| Phone: | (724) 514-1800 |
| Email: | NA |
| Web site: | www.mylan.com |
| CEO: | Heather M Bresch |
| % Owned By | Shares Bought In Last 90 Days | Shares Sold In Last 90 Days | |
| Insiders | NA | 588,239 | 287,811 |
| Institutional | 91.12% | NA | NA |
| Change in Short Interest as of 3/15/2013 | 12.16% | ||
| Short Interest as % of Float as of 3/15/2013 | 9.93% | ||
| Number of Employees | 20,000 |
|---|---|
| Revenue per Employee | $342,016 |
| Income per Employee | $32,043 |
| Market Capitalization (thousands) | $11,324,600 |
| Enterprise Value (thousands) | $16,791,676 |
| Auditors Opinion | Unqualified |
Officers and Directors
Robert J Coury, Rajiv Malik, Heather M Bresch, Harry A Korman, John D Sheehan, Andrew G Cuneo, Anthony Mauro, Neil F Dimick, Clarence B Todd, Randall L Vanderveen, Robert J Cindrich, Joseph C Maroon, Melina E Higgins, Wendy Cameron, Rodney L Piatt, Mark W Parrish, Douglas J Leech, Bryan G Byala, Daniel C Rizzo, Michael B Laffin, Nina Devlin, Kris King, Leah Summers, Eric M Leeds, Joseph F Haggerty
